Researchers believe they've come up with a new biomarker blood test that can diagnose heart attack much more quickly than existing tests allow and thereby reduce the potential for long-term harm.
An experimental gene therapy developed by investigators at the Icahn School of Medicine at Mount Sinai successfully regenerated heart muscle in pigs following a heart attack.
High-density lipoproteins are a key component in the transportation of molecules such as cholesterol and fats inside the body. And by using a synthetic nanoparticle version of these natural vehicles, researchers have found a way to deliver drugs to the heart that could potentially prevent repeat heart attacks or stroke.
A microparticle therapy developed by researchers at Northwestern Medicine and the University of Sydney in Australia may be able to restore heart tissue damaged by inflammation following a heart attack.
GlaxoSmithKline has racked up a slate of drug approvals this year, an impressive accomplishment for a company that had to endure a lengthy fallow period in R&D after it reorganized its extensive research operations.
When a patient succumbs to a heart attack, the cardiologist places a stent to open the offending artery. But adding multiple, preventive stents seems to produce better outcomes than just one, U.K. researchers conclude in a new study.
An Abbott Diagnostics assay wowed researchers by identifying far more female patients likely to suffer heart attacks than current technology allows.
Scientists think they have a litmus test for acute coronary syndrome that may also solve emergency room overcrowding. Researchers believe they've found a biomarker that can instantly determine which patients with chest pain are actually at risk of heart attack and which can be safely discharged.
With flu vaccines arriving in pharmacies and National Immunization Awareness Month well under way, the benefits of vaccines have been well documented in recent weeks. And a new study shows flu vaccines may provide even more benefits than originally thought.
An investigative team of heart experts has tracked down a pair of biomarkers they say can flag people who are at risk of having "silent strokes," asymptomatic events that can quietly damage the brain and leave them threatened by even worse incidents of heart and vascular disease.